Top Markets
Coin of the day
Pear Therapeutics, Inc. Pear Therapeutics, Inc.

Pear Therapeutics, Inc.

PEAR
Classifica tra le azioni #40500
Pear Therapeutics, Inc. is a commercial-phase medical company focused on... Pear Therapeutics, Inc. is a commercial-phase medical company focused on inventing and distributing digital therapeutics. Its current offerings include reSET, which addresses substance use disorders involving alcohol, cannabis, cocaine, and stimulants; reSET-O, prescribed alongside buprenorphine for opioid use disorder; and Somryst, a digital solution for chronic insomnia. Beyond these marketed therapies, the company maintains a robust development pipeline of 14 prospective products. These investigational treatments span various therapeutic areas, encompassing psychiatry, neurology, and non-central nervous system conditions like gastrointestinal, oncological, and cardiovascular disorders. Founded in 2013, Pear Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Prezzo delle azioni
$0.0048
Ultima sincronizzazione: 2023-05-23
Capitalizzazione di mercato
$132.48K
Variazione (1 giorno)
-20.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Pear Therapeutics, Inc. (PEAR)

Categoria

Storico del rendimento da dividendi per Pear Therapeutics, Inc. (PEAR)
Il rendimento da dividendi (TTM) di Pear Therapeutics, Inc. (simbolo azionario: PEAR) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Pear Therapeutics, Inc. (PEAR) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti